RE: Tonight Conference call
I don,t think they have anything to report.
We wait for test results from hereon.
Progression free survival is the goal - the longer the better...
It's kind of stupid. Market knew that Avastin wasn't effective but palliative yet market is willing to go bullish on Genentech.
This company has something effective and market is ignoring it.
Go figure.